Result Number | Material Type | Add to My Shelf Action | Record Details and Options |
---|---|---|---|
1 |
Material Type: Article
|
Pembrolizumab plus Chemotherapy in Advanced Endometrial CancerThe New England journal of medicine, 2023-06, Vol.388 (23), p.2159-2170 [Peer Reviewed Journal]Copyright © 2023 Massachusetts Medical Society. All rights reserved. ;Copyright © 2023 Massachusetts Medical Society. ;ISSN: 0028-4793 ;EISSN: 1533-4406 ;DOI: 10.1056/NEJMoa2302312 ;PMID: 36972022Full text available |
|
2 |
Material Type: Article
|
Dostarlimab for Primary Advanced or Recurrent Endometrial CancerThe New England journal of medicine, 2023-06, Vol.388 (23), p.2145-2158 [Peer Reviewed Journal]Copyright © 2023 Massachusetts Medical Society. All rights reserved. ;Copyright © 2023 Massachusetts Medical Society. ;ISSN: 0028-4793 ;ISSN: 1533-4406 ;EISSN: 1533-4406 ;DOI: 10.1056/NEJMoa2216334 ;PMID: 36972026Full text available |
|
3 |
Material Type: Article
|
Perioperative Nivolumab and Chemotherapy in Stage III Non–Small-Cell Lung CancerThe New England journal of medicine, 2023-08, Vol.389 (6), p.504-513 [Peer Reviewed Journal]Copyright © 2023 Massachusetts Medical Society. All rights reserved. ;Copyright © 2023 Massachusetts Medical Society. ;ISSN: 0028-4793 ;EISSN: 1533-4406 ;DOI: 10.1056/NEJMoa2215530 ;PMID: 37379158Full text available |
|
4 |
Material Type: Article
|
New Horizons in the Treatment of OsteosarcomaThe New England journal of medicine, 2021-11, Vol.385 (22), p.2066-2076 [Peer Reviewed Journal]Copyright © 2021 Massachusetts Medical Society. All rights reserved. ;COPYRIGHT 2021 Massachusetts Medical Society ;ISSN: 0028-4793 ;EISSN: 1533-4406 ;DOI: 10.1056/NEJMra2103423Full text available |
|
5 |
Material Type: Article
|
Pembrolizumab for Persistent, Recurrent, or Metastatic Cervical CancerThe New England journal of medicine, 2021-11, Vol.385 (20), p.1856-1867 [Peer Reviewed Journal]Copyright © 2021 Massachusetts Medical Society. All rights reserved. ;Copyright © 2021 Massachusetts Medical Society. ;COPYRIGHT 2021 Massachusetts Medical Society ;ISSN: 0028-4793 ;EISSN: 1533-4406 ;DOI: 10.1056/NEJMoa2112435 ;PMID: 34534429Full text available |
|
6 |
Material Type: Article
|
Human Epidermal Growth Factor Receptor 2 Testing in Breast Cancer: American Society of Clinical Oncology/College of American Pathologists Clinical Practice Guideline Focused UpdateArchives of pathology & laboratory medicine (1976), 2018-11, Vol.142 (11), p.1364-1382 [Peer Reviewed Journal]COPYRIGHT 2018 College of American Pathologists ;Copyright College of American Pathologists Nov 2018 ;ISSN: 0003-9985 ;ISSN: 1543-2165 ;EISSN: 1543-2165 ;DOI: 10.5858/arpa.2018-0902-sa ;PMID: 29846104Full text available |
|
7 |
Material Type: Article
|
Perioperative Pembrolizumab for Early-Stage Non–Small-Cell Lung CancerThe New England journal of medicine, 2023-08, Vol.389 (6), p.491-503 [Peer Reviewed Journal]Copyright © 2023 Massachusetts Medical Society. All rights reserved. ;Copyright © 2023 Massachusetts Medical Society. ;ISSN: 0028-4793 ;EISSN: 1533-4406 ;DOI: 10.1056/NEJMoa2302983 ;PMID: 37272513Full text available |
|
8 |
Material Type: Article
|
Sotorasib in KRAS p.G12C–Mutated Advanced Pancreatic CancerThe New England journal of medicine, 2023-01, Vol.388 (1), p.33-43 [Peer Reviewed Journal]Copyright © 2022 Massachusetts Medical Society. All rights reserved. ;Copyright © 2022 Massachusetts Medical Society. ;COPYRIGHT 2023 Massachusetts Medical Society ;ISSN: 0028-4793 ;EISSN: 1533-4406 ;DOI: 10.1056/NEJMoa2208470 ;PMID: 36546651Full text available |
|
9 |
Material Type: Article
|
Gastroenteropancreatic Neuroendocrine TumorsCA: a cancer journal for clinicians, 2018-11, Vol.68 (6), p.471-487 [Peer Reviewed Journal]2018 American Cancer Society ;2018 American Cancer Society. ;Copyright Wiley Subscription Services, Inc. Nov/Dec 2018 ;ISSN: 0007-9235 ;EISSN: 1542-4863 ;DOI: 10.3322/caac.21493 ;PMID: 30295930Full text available |
|
10 |
Material Type: Article
|
Survival Outcomes for Metaplastic Breast Cancer Differ by Histologic SubtypeAnnals of surgical oncology, 2021-08, Vol.28 (8), p.4245-4253 [Peer Reviewed Journal]Society of Surgical Oncology 2021 ;Society of Surgical Oncology 2021. ;ISSN: 1068-9265 ;EISSN: 1534-4681 ;DOI: 10.1245/s10434-020-09430-5 ;PMID: 33389291Full text available |
|
11 |
Material Type: Article
|
Adagrasib with or without Cetuximab in Colorectal Cancer with Mutated KRAS G12CThe New England journal of medicine, 2023-01, Vol.388 (1), p.44-54 [Peer Reviewed Journal]Copyright © 2022 Massachusetts Medical Society. All rights reserved. ;Copyright © 2022 Massachusetts Medical Society. ;COPYRIGHT 2023 Massachusetts Medical Society ;ISSN: 0028-4793 ;EISSN: 1533-4406 ;DOI: 10.1056/NEJMoa2212419 ;PMID: 36546659Full text available |
|
12 |
Material Type: Article
|
Dabrafenib plus Trametinib in Pediatric Glioma with BRAF V600 MutationsThe New England journal of medicine, 2023-09, Vol.389 (12), p.1108-1120 [Peer Reviewed Journal]Copyright © 2023 Massachusetts Medical Society. All rights reserved. ;ISSN: 0028-4793 ;EISSN: 1533-4406 ;DOI: 10.1056/NEJMoa2303815Full text available |
|
13 |
Material Type: Article
|
Dabrafenib in patients with BRAFV600E -positive advanced non-small-cell lung cancer: a single-arm, multicentre, open-label, phase 2 trialThe lancet oncology, 2016-05, Vol.17 (5), p.642-650 [Peer Reviewed Journal]Elsevier Ltd ;2016 Elsevier Ltd ;Copyright Elsevier Limited May 2016 ;ISSN: 1470-2045 ;EISSN: 1474-5488 ;DOI: 10.1016/S1470-2045(16)00077-2 ;CODEN: LANCAOFull text available |
|
14 |
Material Type: Article
|
Preoperative Treatment of Locally Advanced Rectal CancerThe New England journal of medicine, 2023-07, Vol.389 (4), p.322-334 [Peer Reviewed Journal]Copyright © 2023 Massachusetts Medical Society. All rights reserved. ;Copyright © 2023 Massachusetts Medical Society. ;ISSN: 0028-4793 ;EISSN: 1533-4406 ;DOI: 10.1056/NEJMoa2303269 ;PMID: 37272534Full text available |
|
15 |
Material Type: Article
|
Pembrolizumab plus Chemotherapy in Advanced Triple-Negative Breast CancerThe New England journal of medicine, 2022-07, Vol.387 (3), p.217-226 [Peer Reviewed Journal]Copyright © 2022 Massachusetts Medical Society. All rights reserved. ;ISSN: 0028-4793 ;EISSN: 1533-4406 ;DOI: 10.1056/NEJMoa2202809Full text available |
|
16 |
Material Type: Article
|
Trifluridine–Tipiracil and Bevacizumab in Refractory Metastatic Colorectal CancerThe New England journal of medicine, 2023-05, Vol.388 (18), p.1657-1667 [Peer Reviewed Journal]Copyright © 2023 Massachusetts Medical Society. All rights reserved. ;Copyright © 2023 Massachusetts Medical Society. ;ISSN: 0028-4793 ;EISSN: 1533-4406 ;DOI: 10.1056/NEJMoa2214963 ;PMID: 37133585Full text available |
|
17 |
Material Type: Article
|
Adagrasib in Non–Small-Cell Lung Cancer Harboring a KRASG12C MutationThe New England journal of medicine, 2022-07, Vol.387 (2), p.120-131 [Peer Reviewed Journal]Copyright © 2022 Massachusetts Medical Society. All rights reserved. ;ISSN: 0028-4793 ;EISSN: 1533-4406 ;DOI: 10.1056/NEJMoa2204619Full text available |
|
18 |
Material Type: Article
|
A unique carrier for delivery of therapeutic compounds beyond the blood-brain barrierPloS one, 2008-06, Vol.3 (6), p.e2469-e2469 [Peer Reviewed Journal]COPYRIGHT 2008 Public Library of Science ;2008 Karkan et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License (the “License”), which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;Karkan et al. 2008 ;ISSN: 1932-6203 ;EISSN: 1932-6203 ;DOI: 10.1371/journal.pone.0002469 ;PMID: 18575595Full text available |
|
19 |
Material Type: Article
|
2019 international clinical practice guidelines for the treatment and prophylaxis of venous thromboembolism in patients with cancerThe lancet oncology, 2019-10, Vol.20 (10), p.e566-e581 [Peer Reviewed Journal]Elsevier Ltd ;2019 Elsevier Ltd ;Copyright © 2019 Elsevier Ltd. All rights reserved. ;2019. Elsevier Ltd ;Attribution - NonCommercial ;ISSN: 1470-2045 ;EISSN: 1474-5488 ;DOI: 10.1016/S1470-2045(19)30336-5 ;PMID: 31492632Full text available |
|
20 |
Material Type: Article
|
The Chinese Society of Clinical Oncology (CSCO): clinical guidelines for the diagnosis and treatment of gastric cancerCancer communications (London, England), 2019-03, Vol.39 (1), p.1-31 [Peer Reviewed Journal]The Author(s) 2019 ;2019. This work is licensed under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;ISSN: 2523-3548 ;EISSN: 2523-3548 ;DOI: 10.1186/s40880-019-0349-9 ;PMID: 30885279Full text available |